NATIXIS Q4 2021 Filing

Filed February 14, 2022

Portfolio Value

$29.3B

Holdings

1,210

Report Date

Q4 2021

Filing Type

13F-HR

All Holdings (1,210 positions)

#	Stock	Shares	Value	% Portfolio	Type
1201	XXII22ND CENTY GROUP INC	11,200	$35.0M	0.12%
1202	—VACCINEX INC	31,895	$33.0M	0.11%
1203	—ALLENA PHARMACEUTICALS	50,000	$30.0M	0.10%
1204	—THERAPEUTICSMD INC	80,000	$28.0M	0.10%
1205	MEIPUSDMEI PHARMA INC	10,000	$27.0M	0.09%
1206	—EPIZYME INC	10,400	$26.0M	0.09%
1207	—ORGANIGRAM HLDGS INC	14,100	$25.0M	0.09%
1208	SNDLEURSUNDIAL GROWERS INC	36,000	$21.0M	0.07%
1209	—HEXO CORP	18,500	$13.0M	0.04%
1210	—HYCROFT MINING HOLDING CORP	23,812	$5.0M	0.02%

PreviousPage 13 of 13